Chris Edwards

Chris Edwards is an accomplished finance executive with extensive experience in leading financial operations across various sectors. Currently serving as Chief Financial Officer at Gannet BioChem since February 2025, Chris previously held the same role at SOLESIS, managing finance activities and driving growth strategies for the company and its subsidiaries. Prior to SOLESIS, Chris worked at inVentiv Health as Vice President of Shared Services, implementing global service models and enhancing operational efficiency. Key roles at ConvaTec and Bristol-Myers Squibb included transforming finance organizations, overseeing large teams, and supporting significant business growth initiatives. Chris holds an MBA in Accounting and Finance from The University of Manchester and is a member of the Chartered Institute of Management Accountants, having earned a CIMA designation.